Skip to main content

Sirona Biochem Corp(SBM-X)
TSX Venture

Today's Change
Delayed Last Update

Sirona Biochem Renews Agreement with CURE Intelligence for Marketing and Communications Support

Globe Newswire - Tue Jan 18, 2022

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that it has renewed an agreement with Luxembourg-based analytics and marketing specialist CURE Intelligence for marketing intelligence services and communications support.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

inside the market
Short sales on the TSX: What bearish investors are betting against
Larry MacDonald